Key result
Neuronal NO synthase (nNOS) deficiency or inhibition prolongs left ventricular myocyte relaxation by decreasing protein kinase A-mediated phospholamban phosphorylation and sarcoplasmic reticulum Ca2+ reuptake.
Why the study?
Does neuronal NO synthase deficiency impair left ventricular relaxation via altered phospholamban phosphorylation in mouse myocytes?
Does neuronal NO synthase deficiency impair left ventricular relaxation via altered phospholamban phosphorylation in mouse myocytes?
Myocardial nNOS promotes left ventricular relaxation by regulating protein kinase A-mediated phosphorylation of phospholamban and sarcoplasmic reticulum Ca2+ reuptake via a cGMP-independent effect on protein phosphatase activity.
nNOS modulation of LV relaxation in mice does not inform practice; leaves open human translation and therapeutic targeting.
Stimulation of nitric oxide (NO) release from the coronary endothelium facilitates myocardial relaxation via a cGMP-dependent reduction in myofilament Ca2+ sensitivity. Recent evidence suggests that NO released by a neuronal NO synthase (nNOS) in the myocardium can also hasten left ventricular relaxation; however, the mechanism underlying these findings is uncertain. Here we show that both relaxation (TR50) and the rate of [Ca2+]i transient decay (tau) are significantly prolonged in field-stimulated or voltage-clamped left ventricular myocytes from nNOS-/- mice and in wild-type myocytes (nNOS+/+) after acute nNOS inhibition. Disabling the sarcoplasmic reticulum abolished the differences in TR50 and tau, suggesting that impaired sarcoplasmic reticulum Ca2+ reuptake may account for the slower relaxation in nNOS-/- mice. In line with these findings, disruption of nNOS (but not of endothelial NOS) decreased phospholamban phosphorylation (P-Ser16 PLN), whereas nNOS inhibition had no effect on TR50 or tau in PLN-/- myocytes. Inhibition of cGMP signaling had no effect on relaxation in either group whereas protein kinase A inhibition abolished the difference in relaxation and PLN phosphorylation by decreasing P-Ser16 PLN and prolonging TR50 in nNOS+/+ myocytes. Conversely, inhibition of type 1 or 2A protein phosphatases shortened TR50 and increased P-Ser16 PLN in nNOS-/- but not in nNOS+/+ myocytes, in agreement with data showing increased protein phosphatase activity in nNOS-/- hearts. Taken together, our findings identify a novel mechanism by which myocardial nNOS promotes left ventricular relaxation by regulating the protein kinase A-mediated phosphorylation of PLN and the rate of sarcoplasmic reticulum Ca2+ reuptake via a cGMP-independent effect on protein phosphatase activity.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2007) studied Myocardial relaxation. nNOS deficiency or inhibition vs. Wild-type (nNOS+/+) myocytes was evaluated on Relaxation (TR50) and rate of [Ca2+]i transient decay (tau). Neuronal NO synthase (nNOS) deficiency or inhibition prolongs left ventricular myocyte relaxation by decreasing protein kinase A-mediated phospholamban phosphorylation and sarcoplasmic reticulum Ca2+ reuptake.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: